SRTA
Strata Critical Medical, Inc. NASDAQ Listed Nov 5, 2019$5.34
Mkt Cap $461.6M
52w Low $2.84
78.6% of range
52w High $6.02
50d MA $4.52
200d MA $4.71
P/E (TTM)
10.2x
EV/EBITDA
-31.1x
P/B
1.5x
Debt/Equity
0.0x
ROE
14.8%
P/FCF
-6.8x
RSI (14)
—
ATR (14)
—
Beta
2.11
50d MA
$4.52
200d MA
$4.71
Avg Volume
756.7K
Strata Critical Medical, Inc. provides time critical logistics solutions and specialized medical services to healthcare providers across the United States. The company operates as both an air and ground transporter of human organs for transplant. The company was formerly known as Blade Air Mobility, Inc. and change its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.
31 Hudson Yards · New York, NY 10001 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | BMO | 0.01 | -0.06 | -721.0% | 4.80 | +1.0% | +1.9% | -2.9% | -4.4% | +0.7% | +1.8% | — |
| Nov 10, 2025 | BMO | -0.02 | -0.06 | -200.0% | 4.85 | -1.0% | +3.9% | +1.2% | -4.1% | -2.0% | -7.1% | — |
| Aug 5, 2025 | BMO | -0.04 | -0.05 | -25.0% | 4.16 | -1.2% | -7.0% | -2.6% | +4.5% | +7.4% | +6.4% | — |
| May 12, 2025 | BMO | -0.11 | -0.04 | +63.6% | 3.46 | -0.3% | -0.3% | +0.3% | -1.4% | +3.2% | -2.6% | — |
| Mar 13, 2025 | BMO | -0.12 | -0.12 | +0.0% | 3.03 | +2.6% | +3.6% | +1.3% | -3.8% | -1.3% | -0.3% | — |
| Nov 12, 2024 | BMO | -0.06 | -0.03 | +50.0% | 3.49 | +1.4% | +4.9% | -6.6% | -7.6% | -1.9% | +6.1% | — |
| Aug 7, 2024 | BMO | -0.06 | -0.06 | +0.0% | 2.77 | +6.1% | +17.3% | -7.4% | -4.7% | +4.9% | -3.7% | — |
| May 7, 2024 | BMO | -0.13 | -0.06 | +53.8% | 3.58 | -0.6% | -2.2% | +2.6% | -2.5% | -3.7% | +9.2% | — |
| Mar 12, 2024 | BMO | -0.13 | -0.23 | -76.9% | 2.78 | +2.9% | -2.5% | -3.3% | +3.1% | -5.6% | -3.9% | — |
| Nov 8, 2023 | BMO | -0.10 | 0.00 | +103.6% | 2.94 | +1.4% | +7.1% | +1.3% | +2.8% | +8.2% | +4.2% | — |
| Aug 9, 2023 | BMO | -0.14 | -0.11 | +21.4% | 3.82 | +1.0% | -3.5% | +2.6% | -1.3% | -4.8% | -1.1% | — |
| May 11, 2023 | BMO | -0.21 | -0.14 | +33.3% | 3.09 | +1.0% | +1.9% | -1.6% | -4.5% | +3.0% | +3.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 17 | Lake Street | Maintains | Buy → Buy | — | $4.90 | $5.00 | +2.0% | +6.1% | +12.1% | -2.1% | +2.8% | -5.3% |
| Oct 29 | JP Morgan | Maintains | Overweight → Overweight | — | $3.79 | $3.79 | +0.0% | +0.5% | -1.8% | -3.7% | +0.0% | -0.3% |
| Aug 22 | Citigroup | Maintains | Buy → Buy | — | $3.58 | $3.61 | +0.8% | +0.6% | -4.2% | -8.7% | -1.3% | +4.2% |
| Aug 10 | Credit Suisse | Maintains | Outperform → Outperform | — | $3.82 | $3.86 | +1.0% | -3.5% | +2.6% | -1.3% | -4.8% | -1.1% |
| May 12 | Oppenheimer | Maintains | Outperform → Outperform | — | $3.09 | $3.12 | +1.0% | +1.9% | -1.6% | -4.5% | +3.0% | +3.0% |
| May 12 | Credit Suisse | Maintains | Outperform → Outperform | — | $3.09 | $3.12 | +1.0% | +1.9% | -1.6% | -4.5% | +3.0% | +3.0% |
| Mar 15 | Credit Suisse | Maintains | Outperform → Outperform | — | $3.52 | $3.50 | -0.6% | +3.4% | -5.5% | -9.0% | -2.2% | +6.5% |
| Mar 15 | JP Morgan | Maintains | Overweight → Overweight | — | $3.52 | $3.50 | -0.6% | +3.4% | -5.5% | -9.0% | -2.2% | +6.5% |
| Mar 15 | Oppenheimer | Maintains | Outperform → Outperform | — | $3.52 | $3.50 | -0.6% | +3.4% | -5.5% | -9.0% | -2.2% | +6.5% |
| Jan 26 | JP Morgan | Maintains | Overweight → Overweight | — | $4.34 | $4.38 | +0.9% | +1.2% | +2.7% | -2.9% | +1.8% | +2.2% |
| Nov 10 | Credit Suisse | Maintains | Outperform → Outperform | — | $4.56 | $4.81 | +5.5% | +1.1% | -1.3% | +3.5% | +6.2% | -2.0% |
| Oct 18 | JP Morgan | Maintains | Overweight → Overweight | — | $3.84 | $3.92 | +2.2% | -5.7% | +1.9% | +3.3% | +2.6% | -0.8% |
| May 12 | Deutsche Bank | Maintains | Buy → Buy | — | $5.60 | $5.42 | -3.2% | +4.8% | +13.3% | -0.3% | +5.9% | +0.1% |
| May 11 | Credit Suisse | Maintains | Outperform → Outperform | — | $6.15 | $6.05 | -1.6% | -8.9% | +4.8% | +13.3% | -0.3% | +5.9% |
| Sep 28 | Oppenheimer | Maintains | Outperform → Outperform | — | $11.27 | $11.07 | -1.8% | -3.5% | -5.2% | +0.9% | +1.0% | -3.3% |
| Sep 9 | JP Morgan | Maintains | Overweight → Overweight | — | $8.79 | $9.50 | +8.1% | +18.8% | -5.7% | -5.7% | +3.9% | +3.7% |
| Sep 2 | Deutsche Bank | Maintains | Buy → Buy | — | $8.85 | $8.95 | +1.1% | +1.6% | -1.6% | +0.3% | -1.0% | +18.8% |
| Sep 1 | Deutsche Bank | Maintains | Buy → Buy | — | $8.51 | $8.65 | +1.6% | +4.0% | +1.6% | -1.6% | +0.3% | -1.0% |
| Jun 3 | Citigroup | Maintains | Buy → Buy | — | $9.77 | $10.10 | +3.4% | +12.4% | -2.2% | -1.2% | -2.9% | -0.7% |
No insider trades available.
8-K · 2.02
!! High
Strata Critical Medical, Inc. -- 8-K 2.02: Earnings Results
Strata Critical Medical reported Q1 2026 financial results, providing investors with updates on operational performance and financial condition for the quarter ending March 31, 2026.
May 6
8-K
Strata Critical Medical, Inc. -- 8-K Filing
Strata Critical Medical reported Q4 2025 earnings from continuing operations, suggesting the company has divested or discontinued certain business segments.
Mar 3
8-K · 1.01
! Medium
Strata Critical Medical, Inc. -- 8-K 1.01: Financing / Debt Agreement
Strata Critical Medical secured a $30 million credit agreement, providing liquidity for operations and potential growth investments while expanding its borrowing capacity.
Feb 5
Data updated apr 27, 2026 2:52am
· Source: massive.com